SCHEMBL5730271

SCHEMBL5730271

CC(C)(C)[Si](C)(C)n1cc(OBOc2cn([Si](C)(C)C(C)(C)C)c3c(Cl)cccc23)c2cccc(Cl)c21

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3450328 0.77 KDM4E (0.31)
SCHEMBL4486828 0.75 PRMT5 (0.32) PRMT5
SCHEMBL29957143 0.75 PRMT5 (0.32) PRMT5
SCHEMBL4498158 0.66 PRMT5 (0.39) PRMT5
SCHEMBL4313476 0.63 NOTUM (0.45)
SCHEMBL29953424 0.58 SSTR4 (0.30)
SCHEMBL2723162 0.58 ALDH1A1 (0.45)
SCHEMBL17224442 0.58 KMT2A (0.38)
SCHEMBL263719 0.57 ALDH1A1 (0.42)
SCHEMBL3242496 0.57 CYP1A2 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1615898-B1 2-Aminopyrimidine derivatives and their medical use NOVARTIS AG (CH) 2014-10-29 EP disclosed
EP-1615898-A1 2-AMINOPYRIMIDINE DERIVATIVES AND THEIR MEDICAL USE Novartis AG (CH) 2006-01-18 EP disclosed
WO-2004089913-A1 AMINOPYRIMIDINE DERIVATIVES AND THEIR MEDICAL USE NOVARTIS AG (CH) 2004-10-21 WO disclosed